Logo-bi
Bioimpacts. 2019;9(2): 67-70. doi: 10.15171/bi.2019.09
PMID: 31334037        PMCID: PMC6637218

Editorial

Aptamedicine: a new treatment modality in personalized cancer therapy

Somayeh Vandghanooni 1, Morteza Eskandani 1, Jaleh Barar 1,2 ORCID, Yadollah Omidi 1,2 * ORCID

Cited by CrossRef: 2


1- Fathi M, Safary A, Barar J. Therapeutic impacts of enzyme-responsive smart nanobiosystems. Bioimpacts. 2019;10(1):1 [Crossref]


As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences. 
Acceptance rate: 24% 
Publication fee: Free of charge